Drug-Induced Interstitial Lung Disease in Oncology Patients

• Abramson RG, Abramson VH, Chan E et al (2013) Complixations of targeted drug therapies for solid malignancies: manifestations and mechanisms. AJR 200(3):475–483

  Article  PubMed Central  PubMed  Google Scholar 

• Akoun GM, Cadranel JL, Rosenow EC et al (1991) Bronchoalveolar lavage cell data in drug induced pneumonitis. Allerg Immunol Paris 23(6):245–252

  CAS  PubMed  Google Scholar 

• Araujo MS, Fernandes FL, Kay FU et al (2013) Pneumomediastinum, subcutaneous emphysema, and pneumothorax after a pulmonary function testing in a patient with bleomycin-induced interstitial pneumonitis. J Bras Pneumol 39(5):613–619

  Article  PubMed Central  PubMed  Google Scholar 

• Cha SI, Choi KJ, Shin KM, Lim J, Yoo SS, Lee J, Lee SY, Kim CH, Park JY (2013) Risk factors for rituximab-induced interstitial lung diseases in patients with malignant lymphoma. Respiration 85(2):175

  Article  PubMed  Google Scholar 

• Choueiri TK, Mayer EL, Je Y et al (2011) Congestive heart failure risk in patients with breast cancer treated with bevacizumab. J Clin Oncol 29(6):632–638

  Article  CAS  PubMed  Google Scholar 

• Cleverly J, Screaton N, Hiorns M, Flint JD, Mueller NL (2002) Drug induced lung disease: high-resolution CT and histologic findings. Clin Radiol 57(4):292–299

  Article  Google Scholar 

• Dimopoulou I, Bamias A, Lyberopoulos P, Dimopoulos MA (2006) Pulmonary toxicity from novel antineoplastic agents. Ann Oncol 17(3):372–379

  Article  CAS  PubMed  Google Scholar 

• Dy GK, Adjei AA (2013) Understanding, recognizing and managing toxicities of targeted anticancer therapies. CA Cancer J Clin 63(4):249–279

  Article  PubMed  Google Scholar 

• Ellard SL, Clemons M, Gelmon KA et al (2009) Randomized phase II study comparing two schedules of everolimus in patients with recurrent/metastatic breast cancer: NCIC Clinical Trials Group IND.163. J Clin Oncol 27(27):4536–4541

  Article  CAS  PubMed  Google Scholar 

• Ellis SJ, Cleverley JR, Mueller NL (2000) Drug induced lung disease: high resolution CT findings. AJR 175(4):1019–1024

  Article  CAS  PubMed  Google Scholar 

• Erasmus JJ, McAdams HP, Rossi SE (2002) Drug induced lung injury. Semin Roentgenol 37(1):72–81

  Article  PubMed  Google Scholar 

• Foucher P, Camus P (2008) Pneumotox online: the drug induced lung diseases. See: www.pneumotox.com

• Hall PS, Harshman LC, Srinivas S, Witteles RM (2013) The frequency and severity of cardiovascular toxicity from targeted therapy in advanced renal cell carcinoma patients. JACC Heart Fail 1(1):72–78

  Article  PubMed  Google Scholar 

• Helman DL Jr, Byrd JC, Ales NC, Shorr AF (2002) Fludarabine-related pulmonary toxicity: a distinct clinical entity in chronic lymphoproliferative syndromes. Chest 122(3):785–790

  Article  PubMed  Google Scholar 

• Hitchen L (2006) Adverse drug reactions result in 250.000 UK admissions a year. BMJ 332(7550):1109

  Article  PubMed Central  PubMed  Google Scholar 

• Iacovelli R, Palazzo A, Mezi S, Morano F, Naso G, Cortesi E (2012) Incidence and risk of pulmonary toxicity in patients treated with mTOR inhibitors for malignancy. A meta-analysis of published trials. Acta Oncol 51(7):873–879

  Article  CAS  PubMed  Google Scholar 

• Ioka T, Katayama K, Tanaka S, Takakura R, Ashida R, Kobayashi N, Taniai H (2013) Safety and effectiveness of gemcitabine in 855 patients with pancreatic cancer under Japanese clinical practice based on post-marketing surveillance in Japan. Jpn J Clin Oncol 43(2):139–4015

  Article  PubMed  Google Scholar 

• Iu X, Hong XN, Gu YJ, Wang BY, Luo ZG, Cao J (2008) Interstitial pneumonitis during rituximab-containing chemotherapy for non-Hodgkin lymphoma. Leuk Lymphoma 49(9):1778–1783

  Article  Google Scholar 

• Kang HJ, Park JS, Kim DW et al (2012) Adverse pulmonary reactions associated with the use of monoclonal antibodies in cancer patients. Respir Med 106(3):443–450

  Article  PubMed  Google Scholar 

• Kudoh S, Kato H, Nishiwaki Y et al (2008) Japan Thoracic Radiology group interstitial lung disease in patients with lung cancer: a cohort and nested case-control study. Am J Resp Crit Care Med 177(12):1348–1357

  Article  PubMed  Google Scholar 

• Limper A, Rosenow E (1996) Drug induced interstitial lung disease. Curr Opin Pulm Med 2(5):396–404

  Article  CAS  PubMed  Google Scholar 

• Lioté H, Lioté F, Séroussi B, Mayaud C, Cadranel J (2010) Rituximab-induced lung disease: a systematic literature review. Eur Respir J 35(3):681–687

  Article  PubMed  Google Scholar 

• Mueller NL, White DA, Jiang H, Gemma A (2004) Diagnosis and management of drug associated interstitial lung disease. Br J Cancer 91(Suppl 2):S24–S30

  Article  CAS  Google Scholar 

• Myers JL, Limper AH, Swensen SJ (2003) Drug induced lung disease: a pragmatic classification incorporating HRCT appearances. Sem Resp Crit Care Med 24(4):445–454

  Article  Google Scholar 

• Nalluri SR, Chu D, Keresztes R, Zhu X, Wu S (2008) Risk of venous thromboembolism with the angiogenesis inhibitor bevacizumab in cancer patients: a meta-analysis. JAMA 300(19):2277–2285

  Article  CAS  PubMed  Google Scholar 

• Nicolaides NC, Sass PM, Grasso L (2010) Advances in targeted therapeutic agents. Expert Opin Drug Discov 5(11):1123–1140

  Article  CAS  PubMed  Google Scholar 

• Nieuwenhuizen L, Verzijlbergen FJ, Wiltink E, Grutters JC, Biesma DH (2008) A possible role of 18F-FDG positron-emission tomography scanning in the early detection of rituximab-induced pneumonitis in patients with non-Hodgkin’s lymphoma. Haematologica 93(8):1267–1269

  Article  PubMed  Google Scholar 

• Nozawa M, Ohzeki T, Tamada S et al (2015) Differences in adverse event profiles between everolimus and temsirolimus and the risk factors for non-infectious pneumonitis in advanced renal cell carcinoma. J Immunother 38(7):285–91. doi: 10.1097/CJI.0000000000000090

• Oya N, Sasai K, Tachiiri S et al (2006) Influence of radiation dose rate and lung dose on interstitial pneumonitis after fractionated total body irradiation: acute parotitis may predict interstitial pneumonitis. Int J Hematol 83(1):86–91

  Article  PubMed  Google Scholar 

• Peddi PF, Shatsky RA, Hurvitz SA (2014) Noninfectious pneumonitis with the use of mTOR inhibitors in breast cancer. Cancer Treat Rev 40(2):320–326

  Article  CAS  PubMed  Google Scholar 

• Rossi SE, Erasmus JJ, McAdams HP, Sporn TA, Goodman PC (2000) Pulmonary drug toxicity: radiologic and pathologic manifestations. Radiographics 20:1245–1259

  Article  CAS  PubMed  Google Scholar 

• Satoh T, Gemma A, Kudoh S et al (2014) Incidence and clinical features of drug induced lung injury in patients with advanced colorectal cancer receiving cetuximab: results of a prospective multicenter registry. Jap J Clin Oncol 44(11):1032–3039

  Article  Google Scholar 

• Schwaiblmair M, Behr W, Haeckel T et al (2012) Drug induced interstitial lung disease. Open Respir Med J 6:63–74

  Article  PubMed Central  PubMed  Google Scholar 

• Senkus E, Jassem J (2011) Cardiovascular effects of systemic cancer treatment. Cancer Treat Rev 37(4):300–311

  Article  CAS  PubMed  Google Scholar 

• Shi L, Tang J, Tong L, Liu Z (2014) Risk of interstitial lung disease with gefitinib and erlotinib in advanced non-small cell lung cancer: a systematic review and meta-analysis of clinical trials. Lung Cancer 83(2):231–239

  Article  PubMed  Google Scholar 

• Silva CIS, Mueller NL (2006) Drug induced lung diseases: most common reaction patterns and corresponding high-resolution CT manifestations. Semin Ultrasound CT MR 27:111–116

  Article  PubMed  Google Scholar 

• Simpson A, Paul J, Graham J et al (1998) Fatal bleomycin pulmonary toxicity in the west of Scotland 1991-1995: a review of patients with germ cell tumors. Br J Cancer 78(8):1061–1066

  Article  PubMed Central  CAS  PubMed  Google Scholar 

• Tamura M, Saraya T, Fujiwara M et al (2013) High-resolution computed tomography findings for patients with drug induced pulmonary toxicity, with special reference to hypersensitivity pneumonitis-like patterns in gemcitabine-induced cases. Oncologist 18(4):454–459

  Article  PubMed Central  PubMed  Google Scholar 

• Vahid B, Marik PE (2008) Pulmonary complications of novel antineoplastic agents for solid tumors. Chest 133(2):528–538

  Article  CAS  PubMed  Google Scholar 

• Walsh SL, Hansell DM (2014) High-resolution CT of interstitial lung disease: a continuous evolution. Semin Respir Crit Care Med 35(1):129–144

  Article  PubMed  Google Scholar 

• White DA, Schwartz LH, Dimitrijevic S, Scala LD, Hayes W, Gross SH (2009) Characterization of pneumonitis in patients with advanced non-small cell lung cancer treated with everolimus (RAD001). J Thorac Oncol 4(11):1357–1363

  Article  PubMed  Google Scholar 

Download references